Context Therapeutics Inc.

8-K Delisting notice or listing-rule failure Jul 31, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 26, 2026 8-K Regulation FD disclosure; Other events Jun 15, 2026 8-K Entered a material agreement; Regulation FD disclosure May 18, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Other events May 1, 2026 8-K Regulation FD disclosure; Other events Apr 2, 2026 8-K Regulation FD disclosure; Other events Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Amended charter or bylaws; Other events Mar 13, 2026 8-K Other events Feb 27, 2026 8-K Regulation FD disclosure Jan 8, 2026 8-K Regulation FD disclosure; Other events Nov 5, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Entered a material agreement; Other events Oct 24, 2025 8-K Other events Oct 20, 2025 8-K Delisting notice or listing-rule failure Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Shareholder vote results Jun 12, 2025 8-K Regulation FD disclosure; Other events Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Regulation FD disclosure; Other events Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Delisting notice or listing-rule failure Feb 28, 2025 8-K Regulation FD disclosure; Other events Jan 14, 2025 8-K Director or officer change; Regulation FD disclosure Jan 13, 2025 8-K Other events Dec 23, 2024 8-K Entered a material agreement; Regulation FD disclosure; Other events Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Entered a material agreement; Regulation FD disclosure; Other events Sep 23, 2024 8-K Amended charter or bylaws; Shareholder vote results Sep 17, 2024 8-K Director or officer change; Regulation FD disclosure Sep 4, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Entered a material agreement; Regulation FD disclosure Jul 10, 2024 8-K Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events May 2, 2024 8-K Regulation FD disclosure; Other events Apr 1, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Amended charter or bylaws Mar 21, 2024